Shares of Markel (MKL -0.69%) fell hard after announcing that it would be buying Alterra Capital (NASDAQ: ALTE). Why did the market take this acquisition so badly? In this video, Motley Fool analyst Matt Koppenheffer discusses how this deal is going to cause share dilution for shareholders, and why the market may feel that this "Baby Berkshire"(BRK.A -1.25%) may not have the best track record of growing through acquisitions. He also gives his final thumbs-up or thumbs-down on the deal and tells us why.
You're reading a free article with opinions that may differ from The Motley Fool's Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More
A Brutal Beating for Baby Berkshire
NYSE: BRK.A
Berkshire Hathaway

Markel got punished for closing this deal.
Fool contributor Matt Koppenheffer owns shares of Berkshire Hathaway. The Motley Fool owns shares of Berkshire Hathaway and Markel. Motley Fool newsletter services recommend Berkshire Hathaway and Markel. We Fools don't all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy.
Stocks Mentioned



*Average returns of all recommendations since inception. Cost basis and return based on previous market day close.
Related Articles





Premium Investing Services
Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.